Amyloid-Β as a positive endogenous regulator of release probability at hippocampal synapses

Nature Neuroscience

Volumn 12, Issue 12, 2009, Pages 1567-1576

  Abramov, Efrat ^a   Dolev, Iftach ^a   Fogel, Hilla ^a   Ciccotosto, Giuseppe D ^b   Ruff, Eyal ^a   Slutsky, Inna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME INHIBITION; EXOCYTOSIS; HIPPOCAMPUS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN DEGRADATION; RAT; SYNAPSE; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CA1 REGION, HIPPOCAMPAL; EXCITATORY POSTSYNAPTIC POTENTIALS; MEMBRANE POTENTIALS; NEPRILYSIN; NEURAL INHIBITION; NEURONAL PLASTICITY; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS; PROTEASE INHIBITORS; RATS; SODIUM CHANNEL BLOCKERS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; TETRODOTOXIN; THIORPHAN;

EID: 70549106846     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2433     Document Type: Article

References (50)

1. Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325 (1992).
2. Seubert, P. et al. Isolation and quantifcation of soluble Alzheimer's β-peptide from biological fuids. Nature 359, 325-327 (1992).
3. Shoji, M. et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129 (1992).
4. De Strooper, B. & Annaert, W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857-1870 (2000). (Pubitemid 30386490)
5. Haass, C. Take fve-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J. 23, 483-488 (2004).
6. Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925-937 (2003).
7. Cirrito, J.R. et al. Synaptic activity regulates interstitial fuid amyloid-β levels in vivo. Neuron 48, 913-922 (2005).
8. Cirrito, J.R. et al. Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron 58, 42-51 (2008).
9. Iwata, N., Higuchi, M. & Saido, T.C. Metabolism of amyloid-β peptide and Alzheimer's disease. Pharmacol. Ther. 108, 129-148 (2005).
10. Selkoe, D.J. Clearing the brain's amyloid cobwebs. Neuron 32, 177-180 (2001).
11. Iwata, N. et al. Presynaptic localization of neprilysin contributes to effcient clearance of amyloid-β peptide in mouse brain. J. Neurosci. 24, 991-998 (2004).
12. Devault, A. et al. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 6, 1317-1322 (1987).
13. Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580 (1991).
14. DeKosky, S.T. & Scheff, S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464 (1990).
15. Hsieh, H. et al. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
16. Jacobsen, J.S. et al. Early-onset behavioral and synaptic defcits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103, 5161-5166 (2006).
17. Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875 (2007).
18. Shankar, G.M. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842 (2008).
19. Lesné, S. et al. A specifc amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
20. Hartley, D.M. et al. Protofbrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884 (1999).
21. Ye, C., Walsh, D.M., Selkoe, D.J. & Hartley, D.M. Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation. Neurosci. Lett. 366, 320-325 (2004).
22. Nimmrich, V. et al. Amyloid {β} oligomers (A{β}1-42 globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J. Neurosci. 28, 788-797 (2008).
23. Iwata, N. et al. Identifcation of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150 (2000).
24. Iwata, N. et al. Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552 (2001).
25. Shirotani, K. et al. Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and effciently among thiorphan-and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276, 21895-21901 (2001).
26. Ryan, T.A. et al. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 11, 713-724 (1993).
27. Murthy, V.N., Sejnowski, T.J. & Stevens, C.F. Heterogeneous release properties of visualized individual hippocampal synapses. Neuron 18, 599-612 (1997).
28. Slutsky, I., Sadeghpour, S., Li, B. & Liu, G. Enhancement of synaptic plasticity through chronically reduced Ca2+ fux during uncorrelated activity. Neuron 44, 835-849 (2004).
29. Zakharenko, S.S., Zablow, L. & Siegelbaum, S.A. Visualization of changes in presynaptic function during long-term synaptic plasticity. Nat. Neurosci. 4, 711-717 (2001).
30. Zheng, H. et al. β-Amyloid precursor protein-defcient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531 (1995).
31. Debanne, D., Guerineau, N.C., Gahwiler, B.H. & Thompson, S.M. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fuctuation affects subsequent release. J. Physiol. (Lond.) 491, 163-176 (1996).
32. Dobrunz, L.E. & Stevens, C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18, 995-1008 (1997).
33. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789-791 (2002).
34. Zucker, R.S. & Regehr, W.G. Short-term synaptic plasticity. Annu. Rev. Physiol. 64, 355-405 (2002).
35. Abbott, L.F. & Regehr, W.G. Synaptic computation. Nature 431, 796-803 (2004).
36. Lisman, J.E., Raghavachari, S. & Tsien, R.W. The sequence of events that underlie quantal transmission at central glutamatergic synapses. Nat. Rev. Neurosci. 8, 597-609 (2007).
37. Lisman, J.E. Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci. 20, 38-43 (1997).
38. Katz, B. & Miledi, R. The role of calcium in neuromuscular facilitation. J. Physiol. (Lond.) 195, 481-492 (1968).
39. Lou, X., Scheuss, V. & Schneggenburger, R. Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion. Nature 435, 497-501 (2005).
40. Dawson, G.R. et al. Age-related cognitive defcits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein. Neuroscience 90, 1-13 (1999).
41. Seabrook, G.R. et al. Mechanisms contributing to the defcits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359 (1999).
42. Ohno, M. et al. BACE1 defciency rescues memory defcits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33 (2004).
43. Saura, C.A. et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23-36 (2004).
44. Puzzo, D. et al. Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545 (2008).
45. Palop, J.J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711 (2007).
46. Brody, D.L. et al. Amyloid-β dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224 (2008).
47. Hsia, A.Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228-3233 (1999).
48. Scheff, S.W., DeKosky, S.T. & Price, D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging 11, 29-37 (1990).
49. Buckner, R.L. et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709-7717 (2005).
50. Kaether, C., Skehel, P. & Dotti, C.G. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol. Biol. Cell 11, 1213-1224 (2000).